Dianthus Therapeutics Inc
DNTHHealthcare|Biotechnology|USA
$97.54
-2.41 (-2.41%)
Tangible Book
$22.01
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (17)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Veness Adam M | SVP, General Counsel and Sec. | 2026-06-17 | SELL | 30,000 | $80.8 | $2424K |
| Randhawa Simrat | EVP, Head of R&D | 2026-06-01 | SELL | 26,530 | $90.62 | $2404.1K |
| Soteropoulos Paula | Director | 2026-05-08 | SELL | 599 | $85.47 | $51.2K |
| Savitz Ryan | EVP, CFO & CBO | 2026-04-09 | SELL | 8,224 | $89.84 | $738.8K |
| Savitz Ryan | EVP, CFO & CBO | 2026-03-31 | SELL | 114,367 | $83 | $9492.5K |
| Soteropoulos Paula | Director | 2026-03-31 | SELL | 599 | $80.11 | $48K |
| Soteropoulos Paula | Director | 2026-03-24 | SELL | 27,594 | $78.05 | $2153.7K |
| Garcia Marino | CEO AND PRESIDENT | 2026-03-12 | SELL | 122,918 | $81.49 | $10016.6K |
| CARR EDWARD | CHIEF ACCOUNTING OFFICER | 2026-03-12 | SELL | 43,682 | $81.49 | $3559.6K |
| Randhawa Simrat | EVP, Head of R&D | 2026-03-12 | SELL | 33,830 | $81.48 | $2756.5K |
| Savitz Ryan | CFO & CBO | 2025-12-04 | SELL | 20,000 | $45.18 | $903.6K |
| Randhawa Simrat | EVP, Head of R&D | 2025-11-14 | SELL | 196,538 | $37.55 | $7380K |
| Savitz Ryan | CFO & CBO | 2025-09-09 | SELL | 20,000 | $35 | $700K |
| Fairmount Funds Management LLC | Director, 10% Owner | 2023-09-26 | BUY | 30,000 | $13.15 | $394.5K |
| Randhawa Simrat | Chief Medical Officer | 2023-09-22 | BUY | 4,000 | $13.2 | $52.8K |
| Fairmount Funds Management LLC | Director, 10% Owner | 2023-09-19 | BUY | 30,000 | $13.2 | $396K |
| Fairmount Funds Management LLC | Director, 10% Owner | 2023-09-13 | BUY | 24,254 | $11.2 | $271.6K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked